Inventor · disambiguated record
Oliver Boris Stauch
Also filed as: STAUCH OLIVER BORIS
11 granted patents·21 pending applications·124 citations·filing 2008–2025
91Inventor score
Files withGENENTECH INC13CHUGAI PHARMACEUTICAL CO LTD10HOFFMANN LA ROCHE3GRAUSCHOPF ULLA2ADLER MICHAEL1
Top patents by PatentIndex Score
32 records- 0196US12427193B2Subcutaneous anti-HER2 antibody formulations and uses thereofGENENTECH INC·Filed 2024·Granted Sep 30, 2025·1 cites·4 claims
- 0296US9968676B2Subcutaneous anti-HER2 antibody formulations and uses thereofGENENTECH INC·Filed 2016·Granted May 15, 2018·24 cites·17 claims
- 0395US11767363B2High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 26, 2023·2 cites·6 claims
- 0495US11584798B2High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Feb 21, 2023·2 cites·6 claims
- 0594US11359026B2High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Jun 14, 2022·2 cites·2 claims
- 0694US11008394B2High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted May 18, 2021·6 cites·16 claims
- 0794US9345661B2Subcutaneous anti-HER2 antibody formulations and uses thereofADLER MICHAEL·Filed 2010·Granted May 24, 2016·30 cites·24 claims
- 0894US8568720B2High concentration antibody-containing liquid formulationMORICHIKA TOSHIYUKI·Filed 2008·Granted Oct 29, 2013·53 cites·2 claims
- 0991US2025090660A1Subcutaneous anti-HER2 Antibody Formulations and Uses ThereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1090US2024376219A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1190US2024392017A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1289US2024317869A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1389US2024207400A1Subcutaneous anti-HER2 Antibody Formulations and Uses ThereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 1488US2025197520A1Highly concentrated pharmaceutical formulationsGENENTECH INC·Filed 2024·Application pending·0 cites
- 1587US2023340134A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1684US10280227B2Highly concentrated pharmaceutical formulationsGENENTECH INC·Filed 2014·Granted May 7, 2019·4 cites·15 claims
- 1784US2025257144A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1878US2021353753A1Subcutaneous anti-HER2 Antibody Formulations and Uses ThereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1977US10752696B2Highly concentrated pharmaceutical formulationsGENENTECH INC·Filed 2019·Granted Aug 25, 2020·0 cites·19 claims
- 2072US2021054092A1Highly concentrated pharmaceutical formulationsGENENTECH INC·Filed 2020·Application pending·0 cites
- 2166US2018228895A1Subcutaneous anti-HER2 Antibody Formulations and Uses ThereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 2265US2010074903A1Novel antibody formulationGRAUSCHOPF ULLA·Filed 2009·Application pending·0 cites
- 2364US2014005367A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 2463US2013216532A1Subcutaneous anti-HER2 Antibody Formulations and Uses ThereofGENENTECH INC·Filed 2013·Application pending·0 cites
- 2561US10377831B2Highly concentrated pharmaceutical formulationsGENENTECH INC·Filed 2015·Granted Aug 13, 2019·0 cites·25 claims
- 2661US2016090419A1High concentration antibody-containing liquid formulationHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 2758US2014093512A1Pharmaceutical formulation comprising an antibody against p-selectin and a sugar selected from sucrose and trehaloseHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2857US2013209478A1Formulation comprising an antibody against p-selectinHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2955US2012321638A1Formulation comprising an antibody against p-selectinGRAUSCHOPF ULLA·Filed 2012·Application pending·0 cites
- 3055US2011076273A1Highly Concentrated Pharmaceutical FormulationsGENENTECH INC·Filed 2010·Application pending·0 cites
- 3152US2023241217A1Hydrogel irradiationASCENDIS PHARMA AS·Filed 2021·Application pending·0 cites
- 3234US2013296807A1Drug reconstitution and delivery deviceLINTERN RICHARD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Oliver Boris Stauch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →